Advance your examination of cannabis with Restek’s new Cannabidivarinic Acid norm

Advance your examination of cannabis with Restek’s new Cannabidivarinic Acid norm

Overview

  • Post By : Kumar Jeetendra

  • Source: Restek Corporation

  • Date: 22 Jun,2020

Cannabidivarinic Acid (CBDVA) is a non-psychoactive cannabinoid answered to have mitigating properties. While its therapeutic advantages are as yet being explored, evaluating this compound in cannabis tests is significant for getting a genuine estimation of strength and chemovar distinguishing proof. Restek now offers another CBDVA confirmed reference material (CRM) to assist labs with propelling their examination of cannabis.

Restek’s new CBDVA standard is perfect for making multipoint (5-point least recommended) alignment bends for LC investigation. With confirmed piece and strength, this readied stock item takes out the requirement for in-house measures groundwork for more prominent comfort and lower work necessities. As it’s rejected from U.S. DEA Controlled Substances Act (CSA) administrative controls, no client allows or permitting required to buy inside the U.S., and in light of the fact that it’s produced and QC tried in Restek’s ISO-certify labs, this new CBDVA standard qualifies as a confirmed reference material (CRM) that fulfills your ISO prerequisites.

For CBDVA and other reference norms, Raptor LC sections, test readiness items, and the master meeting your cannabis lab needs.

For more information:https://www.restek.com/news/view/?tag=reference-standards 

About Author